The company is planning to add up to 1,330 jobs over the next eight years, focused mainly on its Regentec division in Indianapolis and its Profile Park in Bloomington, site of a former GE refrigerator factory.
Solinftec said Thursday it would invest $50.6 million to establish operations in the Hoosier state. The company makes technology that helps farmers collect and analyze data to increase crop returns.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
Dr. John Williams, dean since 2010, is stepping down next summer after turning 67, in accordance with university policy. He helped raise more than $70 million and expanded the school’s clinical space by about one-third.
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.
Indiana, one of the largest per-capita energy consumers in the nation, ranks 40th among states for energy efficiency, according to the American Council for an Energy-Efficient Economy.
The society, which has lost more than half its membership in the past two decades, is looking for a new home for many historical items, including a 1910 Waltham Gothic revival grandfather hall clock, a painting by Hoosier artist T.C. Steele and historic medical treatment books and documents.
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Executives and directors of the West Lafayette-based biotech hold nearly 9 percent of Endocyte stock, worth about $177 million, based on the deal price of $24 a share.
A few influential “serial entrepreneurs” in Indiana universities feel an itch to turn their discoveries into products and companies, over and over again.
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
The Bloomington-based maker of medical devices will use the building at 1102 Indiana Ave. to do research on cell and gene therapy in collaboration with the Indiana University School of Medicine and other organizations.
The acquisitions are the first for IEA since it went public this spring, and signal that the company is pushing hard for more growth in the booming renewable energy sector.
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
Jim Litten started with F.C. Tucker in 1972, and today he leads the state's largest independent real estate firm, with 40 offices, 1,500 agents and 400 employees.
Seema Verma, administrator for the Centers for Medicare and Medicaid Services and former health consultant to Mitch Daniels and Mike Pence, visited Indianapolis on Monday to drum up excitement for the program, which now covers about 20 million Americans.
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
